Table 1. Demographics.

Participant Demographics and Baseline Measurements.

Characteristics	Patients n (%)
Total	24
Age in years (Median)	64.3
Range	48 – 84
Race
White	24 (100)
Gender
Female	12 (50)
Male	12 (50)
ECOG* performance status
PS 0	8 (33)
PS 1	15 (63)
PS 2	1 (4)
Smoking status
Smoker	3 (12)
Former smoker	17 (71)
Non smoker	4 (17)
AJCC ‡ clinical stage
IIIB	1 (4)
IV	23 (96)
Histotype of NSCLC
Adenocarcinoma	24 (100)
Previous treatments
Surgical resection	10 (42)
Radiation	13 (54)
Chemotherapy	22 (92)
Tyrosine kinase inhibitor	9 (38)
Metastatic sites
Visceral	17 (71)
Bone	7 (29)
Brain	4 (17)

^*Eastern Cooperative Oncology Group.

^‡American Joint Committee on Cancer